The new news(Macrochem Acquires Option To License Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infection, from Genaera) tells me that there is money in the treatment of infected feet , Macrochem's (sepa) combined with Pexiganan could make it a winning combination.
We need a new update, to get this stock rolling , how are the phase trials coming . With such a low float this could hit 10 dollars a share real quick with great news .
News 
Market Data 
Discover 
